| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $29K | -18.8% | -61.3% |
| Cost of Revenue | $30K | — | -28.8% |
| Gross Profit | -$2K | +87.0% | -105.1% |
| R&D Expense | $288K | -38.4% | -6.6% |
| SG&A Expense | $441K | -11.9% | -24.6% |
| Operating Income | -$1.2M | +23.5% | +32.4% |
| Net Income | -$1.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $7K | +4650.0% | — |
| Inventory | $138K | +0.0% | -71.1% |
| Current Assets | $771K | -49.8% | -87.1% |
| Total Assets | $880K | -47.4% | -85.9% |
| Current Liabilities | $706K | -14.9% | -7.6% |
| Total Liabilities | $706K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.7M | — | — |
| Capital Expenditures | $27K | — | — |
| Investing Cash Flow | -$27K | — | — |
| Financing Cash Flow | $573K | — | — |
| Free Cash Flow | -$3.7M | — | — |
| -180.9% |
| EPS (Basic) | -$0.16 | +20.0% | -900.0% |
| -14.9% |
| -10.1% |
| Stockholders' Equity | $175K | -79.3% | -96.8% |